C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
01/2005
01/05/2005	CN1183092C Intermediates and process for producing fluorine-contg. amino acid compound by using same
01/04/2005	US6838484 Androgen receptor targeting agents which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor
01/04/2005	US6838466 Compounds for the treatment of inflammatory disorders
12/2004
12/30/2004	US20040267025 Compounds for the treatment of metabolic disorders
12/30/2004	US20040266870 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents
12/30/2004	US20040266822 Secondary amines; tissue specificity; reduced side effects; cardiovascular diseases, diabetes, bronchial and urinary smooth muscle spasms, ischemia, anoxic nerve injury
12/30/2004	US20040265742 Photoactive materials
12/29/2004	WO2004113273A1 Pesticidally active ketone and oxime derivatives
12/29/2004	WO2004113270A2 Propionic acid derivatives useful in the treatment of lipid disorders
12/29/2004	WO2004002940A8 Inhibitors of hcv ns5b polymerase
12/29/2004	EP1491524A2 Selective androgen receptor modulators and methods of use thereof
12/29/2004	EP1490328A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
12/29/2004	EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004	EP1206442A4 Substituted chiral allosteric hemoglobin modifiers
12/29/2004	EP1171419B1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
12/29/2004	EP1163209A4 Compounds and compositions for delivering active agents
12/29/2004	EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists
12/29/2004	EP1049474A4 Cannabimimetic lipid amides as useful medications
12/29/2004	EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
12/29/2004	CN1181817C NF-KB inhibitors containing phenylmethyl benzoquinone as active ingredient
12/29/2004	CA2528234A1 Propionic acid derivatives useful in the treatment of lipid disorders
12/28/2004	US6835846 Aliphatic compounds, process for their preparation and their usage
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/23/2004	WO2004110985A1 Pharmaceutically useful salts of carboxylic acid derivates
12/23/2004	WO2004110984A1 Pharmaceutically useful salts of carboxylic acid derivates
12/23/2004	WO2004110983A2 New benzamides as pparϒ modulators
12/23/2004	WO2004110982A1 Processes for preparing (2s)-3-(4-{2-[amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid derivatives
12/23/2004	US20040260108 Metabolites of selective androgen receptor modulators and methods of use thereof
12/23/2004	US20040260092 Coupling a N-phenyl-1-bromo-2-substituted propamide with a substituted hydroxy-, amino-, phosphino-, or seleno- benzene compound; crystallization and filtration; industrial scale, high purity; non-steroidal agonists
12/23/2004	US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents
12/23/2004	CA2528933A1 Processes for preparing (2s)-3-(4-{2-[amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid derivatives
12/23/2004	CA2528932A1 Pharmaceutically useful salts of carboxylic acid derivates
12/23/2004	CA2528231A1 New benzamides as ppar.gamma. modulators
12/23/2004	CA2527608A1 Pharmaceutically useful salts of carboxylic acid derivates
12/22/2004	EP1487796A1 Substituted biaryl amides as c5a receptor modulators
12/22/2004	EP1487786A2 Z-substituted acrylamides, methods for production thereof and agents comprising the same
12/22/2004	EP1487781A2 Process for preparing 2-aminoindan derivatives
12/22/2004	EP1487780A1 Haloacetamide and azide substituted compounds and methods of use thereof
12/22/2004	EP1487458A2 Multi-substitued selective androgen receptor modulators and methods of use thereof
12/22/2004	EP1154990B1 Phthalamide-lanthanide complexes for use as luminescent markers
12/22/2004	EP1086072A4 Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof
12/22/2004	CN1556785A Interfacial method of preparing ester-substituted diaryl carbonates
12/22/2004	CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/22/2004	CN1181049C Alpha-alkylacyl-beta-substituted benzoyl-beta-phenylpropionyl aniline and its synthesis and use
12/22/2004	CN1181048C Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
12/21/2004	US6833460 Preparation and use of gamma-butyrolactones as cross-linking agents
12/21/2004	US6833458 Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates
12/21/2004	CA2322989C Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents
12/16/2004	WO2004108867A2 Cyclohexene carboamides and carbothioamides
12/16/2004	WO2004108659A1 New method for synthesizing ceramide-type compounds
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	US20040254377 Novel processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto
12/16/2004	US20040254334 Preparation and uses for polyarylates
12/16/2004	US20040254225 Modulation of opioid receptor by binding
12/16/2004	CA2526506A1 Inhibitors of papilloma virus
12/15/2004	EP1486483A1 N-biphenylamides and fungicidal compositions containing the same
12/15/2004	EP1485107A1 Phospholipids as caspase inhibitor prodrugs
12/15/2004	EP1485079A2 Small molecule entry inhibitors
12/15/2004	EP1034783B1 Amide derivatives for the treatment of retinal neurodegenerative disorders
12/15/2004	CN1555364A Insecticidal diamides
12/14/2004	US6831197 Intermediates, in particular for preparing fungicides
12/14/2004	US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004	US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/09/2004	US20040248983 Potent analgesic and antiinflammatory effects; antiinflammatory agents; treatment of pain and inflammation; N-(3-cyclohexylphenyl)-4-hydroxy-3-methoxyphenylacetamide
12/09/2004	US20040248894 Controlling blood ingesting, disease spreading pests; biodegradable; nontoxic to humans and animals
12/09/2004	US20040248815 Substituted amino acids as erythropoietin mimetics
12/09/2004	US20040248811 increased oral bioavailability and reduced dosage and regime; epilepsy; pain syndrome therapy
12/09/2004	US20040248026 excellent triboelectric charge property; for electrophotographic toners, nontoxic
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP0920312B1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
12/08/2004	EP0915868B1 Carbanilides used as pesticides
12/08/2004	CN1178900C Anti-tumour agents
12/08/2004	CN1178898C Method for producing N-(3-amino-4-fluorophenyl)-sulphonamides, N-(3-amino-4-fluorophenyl) carboxyic acid amides and N-(3-amino-4-fluorophenyl) carbamates
12/07/2004	US6828460 Resorcinol derivatives
12/07/2004	CA2338685C Herbicidal phenoxypropionic acid n-alkyl-n-2-fluorophenyl amide compounds
12/02/2004	WO2004103074A1 Copper salts of organic acids and use thereof as fungicides
12/02/2004	US20040242916 Process for preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
12/02/2004	US20040242769 Heat-sensitive compounds having a cloud point which can be used as extractants for the separation of metals in aqueous solution
12/02/2004	US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
12/02/2004	US20040242685 Administering -4-benzyloxy-3,5-dimethoxy-N-[(1-dimethylaminocyclopentyl)methyl]benzamide or derivatives for treating disorders responsive to inhibition of the GlyT-2 transporter, such as muscle spasticity, epilepsy and acute, chronic and neuropathic pain
12/02/2004	US20040242652 Beta benzyloxyaspartate derivatives with amino group on benzene ring
12/02/2004	US20040242563 potent, selective and safe inhibitors of Ca2+-activated potassium channel (Gardos channel) of erythrocytes, particularly sickle erythrocytes, and/or of mammalian cell proliferation for treating or preventing cancer, blood vessel proliferative disorders, fibrotic disorders and arteriosclerotic conditions
12/02/2004	US20040242553 Drugs to improve synaptic transmission
12/02/2004	US20040242426 For controlling weeds in agricultural crops
12/01/2004	EP1480947A1 Novel pseudoceramides and cosmetic compositions comprising the same
12/01/2004	EP1180515B9 Benzoxazole compounds, process for the preparation thereof and herbicides
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/25/2004	WO2004101752A2 Compounds for treatment of inflammation, diabetes and related disorders
11/25/2004	WO2004101602A2 Hepatitis c inhibitor peptide analogs
11/25/2004	WO2003101945A8 Ligands that are inhibitors of the rar receptors
11/25/2004	US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
11/25/2004	US20040235959 Insecticidal diamides
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	CA2524780A1 Compounds for treatment of inflammation, diabetes and related disorders
11/24/2004	EP1479666A1 Ester compound and medicinal use thereof
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	EP1159265B1 C-16 unsaturated fp-selective prostaglandins analogs

1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 157